Show simple item record

dc.contributor.advisorMorgan, Julie D.
dc.contributor.advisorBlenkinsopp, Alison
dc.contributor.advisorWong, Christina S.C.
dc.contributor.authorMiller, Elizabeth J.
dc.date.accessioned2019-11-01T13:42:09Z
dc.date.available2019-11-01T13:42:09Z
dc.identifier.urihttp://hdl.handle.net/10454/17392
dc.description.abstractThere is little research investigating factors that facilitate or inhibit timely access to palliative care medicines from community pharmacies. Though palliative care is recognised within the UK government’s strategy and community pharmacists are considered to have a role it is uncertain to what extent this aim is incorporated into local practice. This thesis uses mixed methods to investigate the time taken to access palliative care medication from five community pharmacies in one area of England. The effect of prescription errors, stock availability and other factors is examined. Furthermore, semi-structured interviews with five community pharmacists and eleven other healthcare professionals explore medication access and the community pharmacist’s role in palliative care using the Framework method. Stock availability led to delays with one in five customers going to more than one pharmacy to get urgently required palliative care medications. Legal prescription errors were more common on computer generated prescriptions but did not lead to delays. Three subthemes were identified in accessing palliative care medicines: environment and resources; communication and collaboration; skills and knowledge. The community pharmacist’s role in palliative care was limited due to reluctance from other healthcare professionals to share information, poor access to patient records and lack of integration into the primary healthcare team. This study highlights implications for professionals, commissioners and providers to improve services for those trying to access palliative medication. Community pharmacies remain a largely untapped resource for supporting patients, relatives and carers towards the end of life in both cancer and other advanced life-limiting diseases.en_US
dc.language.isoenen_US
dc.publisherUniversity of Bradforden_US
dc.rights<a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="Creative Commons License" style="border-width:0" src="http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png" /></a><br />The University of Bradford theses are licenced under a <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Licence</a>.eng
dc.subjectCommunity pharmacisten_US
dc.subjectPharmacy servicesen_US
dc.subjectPalliative careen_US
dc.subjectEnd of lifeen_US
dc.subjectOut of hoursen_US
dc.subjectUrgent careen_US
dc.subjectAnticipatory medicinesen_US
dc.subjectDrugsen_US
dc.subjectPharmaceutical servicesen_US
dc.subjectPrescriptionsen_US
dc.titleA Mixed Methods Study Investigating the Community Pharmacist’s Role in Palliative Careen_US
dc.type.qualificationleveldoctoralen_US
dc.publisher.institutionUniversity of Bradfordeng
dc.publisher.departmentFaculty of Life Sciencesen_US
dc.typeThesiseng
dc.type.qualificationnamePhDen_US
dc.date.awarded2017
refterms.dateFOA2019-11-01T13:42:09Z


Item file(s)

Thumbnail
Name:
miller, e.j.pdf
Size:
2.051Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record